Status:
WITHDRAWN
Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Lead Sponsor:
Columbia University
Conditions:
Chronic Fatigue Syndrome
Eligibility:
All Genders
20-70 years
Brief Summary
The purpose of this study is to determine whether therapy that has been shown to be beneficial for mitochondrial diseases is also beneficial for Chronic Fatigue Syndrome (CFS) patients. This study is ...
Detailed Description
The etiology and pathogenesis of chronic fatigue syndrome (CFS) is poorly understood. Although therapies have been proposed, none has been particularly effective. A preceding viral infection is believ...
Eligibility Criteria
Inclusion
- Severe chronic fatigue for 6 or more consecutive months 4 or more of the following 8 symptoms concurrently:
- post-exertion malaise lasting more than 24 hours
- unrefreshing sleep
- significant impairment of short-term memory or concentration
- muscle pain
- pain in the joints without swelling or redness
- headaches of a new type, pattern, or severity
- tender lymph nodes in the neck or armpit
- a sore throat that is frequent or recurring These symptoms should have persisted or recurred during 6 or more consecutive months of illness and they cannot have first appeared before the fatigue.
Exclusion
- Additional medical illnesses causing chronic fatigue
- Ongoing exertion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01872351
Start Date
November 1 2011
End Date
November 1 2012
Last Update
October 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032